Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.86 CAD 2.51% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

Cronos Group Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cronos Group Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Revenue
$111.2m
CAGR 3-Years
19%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Revenue
CA$280.5m
CAGR 3-Years
-21%
CAGR 5-Years
-4%
CAGR 10-Years
88%
Sundial Growers Inc
NASDAQ:SNDL
Revenue
CA$909m
CAGR 3-Years
146%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$348.6m
CAGR 3-Years
13%
CAGR 5-Years
90%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Revenue
$2.3B
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cronos Group Inc
Revenue Breakdown

Breakdown by Geography
Cronos Group Inc

Total Revenue: 87.2m USD
100%
Canada: 64.7m USD
74.2%
Israel: 21.1m USD
24.2%
Other Countries: 1.4m USD
1.6%

Breakdown by Segments
Cronos Group Inc

Total Revenue: 87.2m USD
100%
Cannabis Flower: 62.1m USD
71.1%
Cannabis Extracts: 24.6m USD
28.2%
Other: 602k USD
0.7%

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.61 CAD
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Revenue?
Revenue
111.2m USD

Based on the financial report for Sep 30, 2024, Cronos Group Inc's Revenue amounts to 111.2m USD.

What is Cronos Group Inc's Revenue growth rate?
Revenue CAGR 5Y
38%

Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Cronos Group Inc have been 19% over the past three years , 38% over the past five years .

Back to Top